NIH Discontinues Tenofovir Vaginal Gel in VOICE Study
In a press release last week, the NIH announced it was discontinuing the Tenofovir vaginal gel arm of the VOICE HIV Prevention Study as it has not been shown to be effective in reducing HIV transmission over a placebo gel. This comes two months after the announcement of the discontinuing of the oral tenofovir arm of the study due to inability to demonstrate effectiveness.
Press Release - Tenofovir Gel
Press Release - Oral Tenofovir